Epidemiology of brain metastases
- PMID: 22012633
- DOI: 10.1007/s11912-011-0203-y
Epidemiology of brain metastases
Abstract
Brain metastases are one of the most common neurologic complications of cancer. The incidence is 9%-17% based on various studies, although the exact incidence is thought to be higher. The incidence is increasing with the availability of improved imaging techniques which aid early diagnosis, and effective systemic treatment regimens which prolong life, thus allowing cancer to disseminate to the brain. Lung cancer, breast cancer, and melanoma are the most frequent to develop brain metastases, and account for 67%-80% of all cancers. Most patients with brain metastases have synchronous extracerebral metastases. Some patients present with no known primary cancer diagnosis. In children, brain metastases are rare; germ cell tumors, sarcomas, and neuroblastoma are the common offenders.
Similar articles
-
Incidence of brain metastases in a cohort of patients with carcinoma of the breast, colon, kidney, and lung and melanoma.Cancer. 2002 May 15;94(10):2698-705. doi: 10.1002/cncr.10541. Cancer. 2002. PMID: 12173339
-
Incidence proportions of brain metastases in patients diagnosed (1973 to 2001) in the Metropolitan Detroit Cancer Surveillance System.J Clin Oncol. 2004 Jul 15;22(14):2865-72. doi: 10.1200/JCO.2004.12.149. J Clin Oncol. 2004. PMID: 15254054
-
[Epidemiology of brain metastases].Cancer Radiother. 2015 Feb;19(1):3-9. doi: 10.1016/j.canrad.2014.11.001. Epub 2015 Jan 27. Cancer Radiother. 2015. PMID: 25636729 Review. French.
-
Front-line chemotherapy with cisplatin and etoposide for patients with brain metastases from breast carcinoma, nonsmall cell lung carcinoma, or malignant melanoma: a prospective study.Cancer. 1999 Apr 1;85(7):1599-605. Cancer. 1999. PMID: 10193952 Clinical Trial.
-
[Brain metastases epidemiology and biology].Bull Cancer. 2013 Jan 1;100(1):57-62. doi: 10.1684/bdc.2012.1681. Bull Cancer. 2013. PMID: 23303801 Review. French.
Cited by
-
Rethinking CRITID Procedure of Brain Targeting Drug Delivery: Circulation, Blood Brain Barrier Recognition, Intracellular Transport, Diseased Cell Targeting, Internalization, and Drug Release.Adv Sci (Weinh). 2021 Feb 24;8(9):2004025. doi: 10.1002/advs.202004025. eCollection 2021 May. Adv Sci (Weinh). 2021. PMID: 33977060 Free PMC article. Review.
-
Real-time PACS-integrated longitudinal brain metastasis tracking tool provides comprehensive assessment of treatment response to radiosurgery.Neurooncol Adv. 2022 Jul 26;4(1):vdac116. doi: 10.1093/noajnl/vdac116. eCollection 2022 Jan-Dec. Neurooncol Adv. 2022. PMID: 36043121 Free PMC article.
-
Proteotranscriptomic Profiling of 231-BR Breast Cancer Cells: Identification of Potential Biomarkers and Therapeutic Targets for Brain Metastasis.Mol Cell Proteomics. 2015 Sep;14(9):2316-30. doi: 10.1074/mcp.M114.046110. Epub 2015 Jun 3. Mol Cell Proteomics. 2015. PMID: 26041846 Free PMC article.
-
Density of tertiary lymphoid structures predicts clinical outcome in breast cancer brain metastasis.J Immunother Cancer. 2024 Jul 27;12(7):e009232. doi: 10.1136/jitc-2024-009232. J Immunother Cancer. 2024. PMID: 39067874 Free PMC article.
-
Medical management of brain metastases.Neurooncol Adv. 2020 Aug 9;2(1):vdaa015. doi: 10.1093/noajnl/vdaa015. eCollection 2020 Jan-Dec. Neurooncol Adv. 2020. PMID: 32793881 Free PMC article. Review.
References
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical